Catalyst Wire Dossier Catalyst Wire Dossier

Regranex Gel 0.01%

becaplermin
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Regranex Gel 0.01%, covering 2008-05-07 to 2008-05-07. Get the full timeline:

Most recent: Clinical Trial Update: TheraGauze™ Alone and Regranex®Gel 0.01% Plus TheraGauze™ in the Treatment of Wagner Stage I Diabetic Foot Ulcers [NA]

See pricing